Exane Derivatives Ultragenyx Pharmaceutical Inc. Transaction History

Exane Derivatives

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$45.8 - $85.4 $503 - $939	-11 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$62.2 - $84.4 $684 - $928	11 New	11 $0
Q4 2021 Jan 28, 2022	SELL	$73.71 - $87.86 $810 - $966	-11 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$72.98 - $90.0 $802 - $990	11 New	11 $0
Q3 2020 Oct 06, 2020	SELL	$72.98 - $90.0 $802 - $990	-11 Closed	0 $0
Q2 2019 Jul 12, 2019	SELL	$54.93 - $74.36 $87,338 - $118,232	-1,590 Reduced 99.31%	11 $0
Q1 2019 Apr 24, 2019	BUY	$39.87 - $69.36 $31,218 - $54,308	783 Added 95.72%	1,601 $0
Q4 2018 Jan 31, 2019	BUY	$38.89 - $77.3 $31,812 - $63,231	818 New	818 $35,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.